All In Biotech

Drug Trial Radar · NCT00059332

Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial

Field Administration of Stroke Therapy-Magnesium Trial: A Randomized, Double-Blind, Placebo Controlled Trial of Neuroprotective Magnesium Sulfate Therapy for Acute Stroke Initiated Within 2 Hours of Onset by Paramedics in the Field

Last checked: Nov 20, 2026Latest source record: Aug 21, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,700 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,700

Actual

Start

Jan 2005

Primary completion

Mar 2013

Study completion Mar 2013

Sponsor

Lead sponsor
Jeffrey L. SaverAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
First posted
Apr 24, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 40 years, up to 95 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate the effectiveness and safety of field-initiated magnesium sulfate in improving the long-term functional outcome of patients with acute stroke.

Conditions

  • Cerebrovascular Accident

Interventions

  • Magnesium SulfateDrug

    Paramedics initiate a loading dose of 4 grams magnesium sulfate IV over 15 minutes, followed after hospital arrival by a maintenance infusion of 16 grams magnesium sulfate IV over 24 hours.

  • Normal SalineDrug

    Paramedics initiate a loading dose of placebo normal saline IV over 15 minutes, followed after hospital arrival by a maintenance infusion of placebo normal saline IV over 24 hours.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Modified Rankin ScaleTime frame: 3 months after stroke onset

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Clinical Coordinating Center is: UCLA School of Medicine, 710 Westwood Plaza

    Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.